ClinicalMind Scholarship for Black Pharmacy Students

Click this link to read the Press Release

Description:

The primary goal of the ClinicalMind Scholarship for Black Pharmacy Students is to fund a Black student pursuing a PharmD or Ph.D, in one of the following research areas: rare diseases, gene therapy, small molecule therapeutics or underserved populations.

Eligibility Requirements:

The AFPE recipient must be registered as a full-time student in a Pharm D or Ph.D degree program in the pharmaceutical sciences administered by, or officially affiliated with, an accredited U.S. school or college of pharmacy.
They must be a U.S. citizen or permanent resident.

Award Amount:

The grant is $1,250 will be awarded. There will be no stipulations regarding about combining it with other AFPE awards or awards from other funders, unless those funders have stipulations.

Application Instructions:

Each application will contain:

Completed Application
1 Recommendation Letter attached to your application
Official graduate transcript

2023 Recipients

Margaret Afolabi, University of Illinois at Chicago

Title of Research: Prediction assay of small molecule cancer therapeutics using fresh biopsy and microfluidic device

Summary: Variability in patient responses to cancer therapy highlights the need for personalized treatment based on individual tumor biology. Recent advancements in small molecular drugs offer multiple options for cancer treatment, but selecting the most appropriate drug for each patient remains a challenge. To address this, Margaret’s research aims to develop a high-throughput screening tool using microfluidic chips and fresh core needle biopsies, which can predict the therapeutic effects of small molecular drugs and assist oncologists in making informed treatment decisions.

James Baffoe, The University of Texas at Austin

Title of Research: The impact of perceived discrimination on medication use behaviors among people experiencing homelessness (PEH)

Summary: This project is to understand how perceived discrimination impacts medication adherence among PEH. Study aims include: 1) to characterize the factors associated with PEH’s perceived discrimination during their healthcare encounters, 2) to examine the relationship between PEH’s perceived discrimination with delaying or forgoing their medications, and 3) to examine the relationship between PEH’s perceived discrimination and medication use. To gather this data, a cross-sectional survey (including measures of perceived discrimination and medication adherence) will be conducted in person at community-based sites in Central Texas. Descriptive statistics, bivariate and logistic analyses will be conducted. Study findings are expected to elucidate PEH experiences of discrimination from healthcare providers and the impact that has on medication use behaviors. Findings will be shared with community stakeholders to initiate a dialogue about improving interactions between healthcare providers and PEH to positively impact health behaviors such as medication adherence.